Topic Highlight
Copyright ©2014 Baishideng Publishing Group Inc.
World J Clin Oncol. Oct 10, 2014; 5(4): 730-743
Published online Oct 10, 2014. doi: 10.5306/wjco.v5.i4.730
Table 1 miRNAs involved in chemotherapy response regulation in breast cancer
miRNADrugTarget(s)Ref.
miR-328MitoxantroneBRCP/ABCG2[75]
miR-21DoxorubicinMDR1, PDCD4[81]
miR-451DoxorubicinMDR1[76]
miR-130/107CisplatinRAD51D[125]
miR-345CisplatinMDR1[77]
miR-326VP16/DoxorubicinMRP1[78]
miR-128DoxorubicinBMI1, ABCC5[79]
miR-34aDocetaxelBCL-2, CCND1[83]
miR-125bDoxorubicinBAK1[84]
PaclitaxelE2F3[85]
miR-200b/cDoxorubicinZEB1, PTEN[86,87]
Table 2 miRNAs involved in antiendocrine therapy response in breast cancer
miRNADrugTarget(s)Ref.
miR-221/222TamoxifenP27Kip1[91]
ERα
FulvestrantTGF-β[93]
miR-181bTamoxifenTIMP3[94]
miR-30cTamoxifen[96,97]
miR-342Tamoxifencyclin B1[126]
miR-451Tamoxifen14-3-3ζ[127]
Let-7TamoxifenER-α36[128]
miR-128aLetrozoleTGFαR1[129]